Saturday 17 October 2026
Export PSNL’s income statement to Excel — free account
Personalis, Inc.
PSNL Healthcare Diagnostics & Research
Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
15.65
0.28
−1.76%
Follow PSNL
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | — | — | 3 | 4 | 2 | 4 | 6 | 4 |
Altman Z-Score |
— | — | 1.70 | 14.73 | 4.03 | (1.39) | (3.04) | 0.45 | 3.35 |
P/S ratio |
0.00 | 0.00 | 3.01 | 16.00 | 7.33 | 1.41 | 1.34 | 4.05 | 10.20 |
Altman Z″-Score (non-manufacturers) |
— | (16.47) | 2.08 | 5.35 | 5.39 | 0.14 | (5.75) | (0.99) | 0.31 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | (2.21) | (0.99) | (0.03) | (3.01) | (3.88) | (3.56) | (1.30) |
P/Operating CF |
1,334.41 | 1,334.41 | 81.63 | (497.03) | (41.00) | (5.48) | (7.32) | (43.93) | (31.93) |
P/B ratio |
0.00 | 0.00 | 1.84 | 6.46 | 2.02 | 0.42 | 0.76 | 1.69 | 2.72 |
Price to Tangible BV |
0.00 | 0.00 | 1.84 | 6.46 | 2.02 | 0.42 | 0.76 | 1.69 | 2.72 |
EV/Sales |
0.00 | 0.00 | 1.32 | 13.65 | 4.18 | (0.89) | 0.03 | 2.07 | 7.01 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.54 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
12.12 | 12.12 | (4.76) | (25.16) | (5.04) | 0.82 | (0.04) | (3.89) | (6.52) |
EV/FCF |
(21.53) | (21.53) | (3.25) | (23.38) | (4.36) | 0.48 | (0.03) | (3.77) | (6.15) |
Quick Ratio |
0.50 | 0.42 | 2.63 | 5.16 | 9.76 | 5.56 | 2.79 | 6.21 | 6.46 |
Current Ratio |
0.53 | 0.51 | 2.79 | 5.43 | 10.16 | 6.03 | 3.11 | 6.52 | 6.76 |
Net Debt/EBITDA |
1.08 | 1.84 | 7.24 | 5.65 | 5.01 | 1.57 | 1.13 | 3.08 | 2.93 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.25 | 1.81 | 0.66 | 0.39 | 0.27 | 0.19 | 0.28 | 0.34 | 0.23 |
Operating CF/Net income |
(0.01) | (0.28) | 0.72 | 1.03 | 1.09 | 0.62 | 0.52 | 0.56 | 0.92 |
Capex/Depreciation |
(4.24) | (2.56) | (1.78) | (0.53) | (1.38) | (5.88) | (1.17) | (0.16) | (0.74) |
Interest Coverage |
(17.01) | (7.27) | (19.79) | (21,073.00) | (355.18) | (574.78) | (999.42) | (2,844.46) | (429.55) |
| 23.72% | 19.99% | (16,611.92%) | (27.37%) | (25.82%) | (42.89%) | (62.31%) | (48.91%) | (35.02%) | |
| (62.73%) | (95.45%) | (25.21%) | (20.53%) | (20.34%) | (32.88%) | (41.83%) | (32.82%) | (26.89%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (175.78%) | (143.04%) | (450.20%) | (237.72%) | (259.21%) |
Return on Tangible Assets |
143.35% | 118.09% | (24.18%) | (21.51%) | (21.28%) | (49.59%) | (69.03%) | (36.92%) | (29.75%) |
Average Days of Receivables |
75.27 | 43.07 | 18.47 | 29.47 | 78.85 | 93.38 | 88.07 | 35.11 | 84.91 |
Research and Development Expense of Revenue |
105.60% | 37.87% | 34.38% | 36.32% | 57.68% | 99.79% | 88.15% | 57.80% | 72.17% |
Selling, General and Administrative Expense of Revenue |
105.41% | 29.84% | 33.86% | 42.84% | 55.79% | 98.34% | 67.67% | 54.59% | 76.92% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
8.02% | 3.49% | 7.45% | 10.47% | 16.82% | 29.88% | 19.12% | 12.63% | 13.54% |
Graham Net Nets |
0.34 | 0.34 | 0.45 | 0.14 | 0.37 | 1.36 | 0.52 | 0.40 | 0.27 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(4.91%) | (4.91%) | (28.98%) | (3.25%) | (10.37%) | (123.38%) | (110.29%) | (23.70%) | (11.43%) |
Free Cash Flow Yield |
(3.60%) | (3.60%) | (13.47%) | (3.65%) | (13.08%) | (130.76%) | (68.35%) | (13.58%) | (11.18%) |
Revenue per Share |
3.10 | 12.33 | 3.62 | 2.29 | 1.95 | 1.42 | 1.53 | 1.43 | 0.78 |
Operating CF per Share |
0.10 | 1.82 | (1.00) | (1.24) | (1.61) | (1.54) | (1.17) | (0.76) | (0.84) |
Capex per Share |
(1.70) | (2.56) | (0.47) | (0.09) | (0.25) | (1.09) | (0.23) | (0.02) | (0.05) |
Free Cash Flow per Share |
(1.61) | (0.74) | (1.47) | (1.34) | (1.87) | (2.63) | (1.39) | (0.78) | (0.89) |
Cash per Share |
7.46 | 6.45 | 7.12 | 5.91 | 6.54 | 3.67 | 2.37 | 3.12 | 2.69 |
Shareholders Equity per Share |
0.00 | (34.73) | 5.92 | 5.67 | 7.07 | 4.77 | 2.69 | 3.43 | 2.93 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | (34.73) | 5.92 | 5.67 | 7.07 | 4.77 | 2.69 | 3.43 | 2.93 |
Free Cash Flow |
(4.87) | (2.28) | (26.45) | (45.90) | (81.91) | (120.13) | (67.17) | (46.51) | (79.45) |
Working Capital |
(22.80) | (28.29) | 89.62 | 180.08 | 286.92 | 166.57 | 99.51 | 171.89 | 228.32 |
Capital Expenditures |
(5.16) | (7.85) | (8.38) | (3.25) | (11.08) | (49.90) | (10.91) | (1.36) | (4.50) |
Net Current Asset Value |
26.18 | (118.50) | 88.98 | 170.82 | 232.00 | 125.14 | 51.09 | 135.70 | 194.97 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.55 | 0.21 | 0.13 | 0.04 | 0.13 | 0.77 | 0.15 | 0.02 | 0.06 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.19 | 0.27 | 0.33 | 0.52 | 0.41 | 0.14 | 0.16 | 0.17 | 0.14 |
Cash ROIC |
(21.52%) | 2.63% | (11.26%) | (11.53%) | (13.71%) | (31.14%) | (27.57%) | (11.99%) | (15.85%) |
Accounts Receivable Turnover |
2.94 | 11.82 | 16.81 | 16.30 | 6.89 | 3.71 | 4.28 | 6.54 | 5.72 |
Accounts Payable Turnover |
2.21 | 4.90 | 6.20 | 7.49 | 6.15 | 4.68 | 3.98 | 5.42 | 5.56 |
Inventory Turnover |
7.94 | 12.21 | 10.73 | 11.43 | 9.57 | 7.28 | 5.80 | 7.04 | 8.92 |
Average Days of Payables |
125.49 | 92.27 | 62.10 | 51.76 | 62.52 | 90.75 | 98.53 | 40.40 | 88.01 |
Days of Inventory on Hand |
25.56 | 48.24 | 38.98 | 35.16 | 38.03 | 60.66 | 69.17 | 37.51 | 41.63 |
Average Receivables |
3.20 | 3.20 | 3.88 | 4.82 | 12.41 | 17.56 | 17.19 | 12.94 | 12.17 |
Average Payables |
5.30 | 5.30 | 6.95 | 7.82 | 8.76 | 11.04 | 13.89 | 10.66 | 9.69 |
Average Inventory |
1.48 | 2.13 | 4.02 | 5.12 | 5.62 | 7.10 | 9.53 | 8.21 | 6.04 |
Average Assets |
37.62 | 20.84 | 99.48 | 201.07 | 320.69 | 344.61 | 258.90 | 247.68 | 302.22 |
Average Common Equity |
(99.50) | (99.50) | 0.15 | 150.82 | 252.62 | 264.22 | 173.79 | 166.20 | 232.07 |
Columns are period end dates